iO biotech

iobiotech.com
430 E 29th St Suite 940
New York, NY 10016

Company Info

Year Established
2014

Ticker
IOBT

Exchange
NASD

Contacts

Mai-Britt Zocca, Ph.D.
Founder, President & CEO

Company Description

IO Biotech's mission is to establish their T-win® immune-modulating cancer vaccine as the backbone of combination therapy for people with cancer.